Skip to content

Clinical trials

Primary Myelofibrosis trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Country / region: Greece Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20151
20161
20172
20191
20202
20216
20221
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting7
Completed7
Recruiting3
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
AbbVie4
Karyopharm Therapeutics Inc3
Kartos Therapeutics, Inc.2
Bristol-Myers Squibb1
Celgene1
European Organisation for Research and Treatment of Cancer - EORTC1
Incyte Corporation1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis20
Anemia4
Neoplasms4
Bronchiolitis Obliterans Syndrome2
Leukemia, Myeloid, Acute2
Myeloproliferative Disorders2
Polycythemia Vera2
Thalassemia2
Anemia, Diamond-Blackfan1
Anemia, Sickle Cell1

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.